A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting
Clinical trial NCT03589105 · COMPLETED
Trial details
- NCT number
- NCT03589105
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-06
- Primary completion
- 2021-02-15
- Enrollment
- 423
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.